Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
2,4-dienoyl-CoA reductase 1 | 0.426 | 0.885 | 4.5E-14 |
|
group | 0.070 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 2A | 0.473 | 0.846 | 0.51 |
|
group | 0.030 | None | 1.000 | 2 | 0 | 2006 | 2014 | ||||||||
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase | 0.502 | 0.808 | 2.2E-14 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
acid sensing ion channel subunit 1 | 0.653 | 0.615 | 0.93 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
adducin 1 | 0.612 | 0.615 | 0.99 |
|
group | 0.080 | None | 1.000 | 1 | 0 | 2001 | 2011 | ||||||||
|
adrenoceptor beta 2 | 0.442 | 0.923 | 0.53 |
|
group | 0.070 | None | 1.000 | 3 | 0 | 2004 | 2019 | ||||||||
|
adrenomedullin | 0.436 | 0.808 | 4.1E-02 |
|
group | 0.270 | None | 1.000 | 1 | 0 | 2004 | 2019 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
group | 0.300 | None | 1.000 | 2 | 0 | 2006 | 2019 | ||||||||
|
alpha 2-HS glycoprotein | 0.506 | 0.846 | 3.2E-10 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
group | 0.600 | None | 0.844 | 2 | 0 | 1994 | 2020 | ||||||||
|
angiotensin II receptor type 1 | 0.423 | 0.846 | 5.3E-04 |
|
group | 0.100 | None | 0.917 | 3 | 0 | 2006 | 2019 | ||||||||
|
angiotensinogen | 0.367 | 0.923 | 5.0E-08 |
|
group | 0.100 | None | 1.000 | 2 | 0 | 2001 | 2019 | ||||||||
|
apolipoprotein A1 | 0.429 | 0.885 | 5.5E-04 |
|
group | 0.380 | None | 1.000 | 2 | 0 | 2002 | 2019 | ||||||||
|
apolipoprotein A5 | 0.587 | 0.615 | 5.6E-10 |
|
group | 0.080 | None | 1.000 | 1 | 0 | 2006 | 2019 | ||||||||
|
apolipoprotein B | 0.453 | 0.808 | 1.9E-16 |
|
group | 0.080 | None | 0.875 | 2 | 0 | 2002 | 2019 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
group | 0.100 | None | 0.887 | 3 | 0 | 1995 | 2019 | ||||||||
|
apurinic/apyrimidinic endodeoxyribonuclease 1 | 0.458 | 0.846 | 1.9E-07 |
|
group | 0.030 | None | 1.000 | 1 | 0 | 2007 | 2017 | ||||||||
|
arachidonate 5-lipoxygenase activating protein | 0.612 | 0.731 | 7.1E-02 |
|
group | 0.400 | None | 1.000 | 4 | 0 | 2004 | 2018 | ||||||||
|
C-reactive protein | 0.299 | 0.962 | 3.7E-03 |
|
group | 0.100 | None | 0.963 | 6 | 0 | 2001 | 2020 | ||||||||
|
C-X3-C motif chemokine receptor 1 | 0.457 | 0.885 | 6.1E-02 |
|
group | 0.050 | None | 0.800 | 1 | 0 | 2005 | 2019 | ||||||||
|
carboxypeptidase B2 | 0.536 | 0.846 | 2.7E-17 |
|
group | 0.060 | None | 0.833 | 2 | 0 | 2005 | 2018 | ||||||||
|
CD14 molecule | 0.392 | 0.885 | 4.9E-05 |
|
group | 0.060 | None | 1.000 | 1 | 0 | 2002 | 2017 | ||||||||
|
coagulation factor II thrombin receptor | 0.444 | 0.846 | 8.5E-03 |
|
group | 0.060 | None | 1.000 | 1 | 0 | 2003 | 2019 | ||||||||
|
coagulation factor II, thrombin | 0.415 | 0.885 | 1.1E-03 |
|
group | 0.500 | None | 0.946 | 4 | 0 | 1995 | 2020 | ||||||||
|
coagulation factor III, tissue factor | 0.415 | 0.846 | 1.9E-02 |
|
group | 0.090 | None | 1.000 | 1 | 0 | 1997 | 2019 |